'Inflammatory' cytokines' neuromodulators in normal brain?

Journal of Neurochemistry

Volumn 74, Issue 2, 2000, Pages 457-471

  Vitkovic, Ljubisa ^a   Bockaert, Joël ^a   Jacque, Claude ^b  

^a INSERM   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Behavior; Brain; CNS; Glia; Interleukin 1; Neurons; Tumor necrosis factor

Indexed keywords

CALCIUM ION; CYTOKINE; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1ALPHA; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

BEHAVIOR; BRAIN; CALCIUM SIGNALING; CELL SPECIFICITY; CYTOKINE PRODUCTION; GLIA CELL; HUMAN; NERVE CELL PLASTICITY; NEUROMODULATION; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY; SLEEP;

ANIMALS; BRAIN; CYTOKINES; HUMANS; INFLAMMATION MEDIATORS; NEURONS; NEUROTRANSMITTER AGENTS; REFERENCE VALUES;

EID: 0033983153     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2000.740457.x     Document Type: Short Survey

References (148)

1. Arend W. (1991) Interleukin-1 receptor antagonist. J. Clin. Invest. 88, 1445-1451.
2. Ban E., Milon G., Prudhomme N., Fillion G., and Haour F. (1991) Receptors for interleukin-1 (alpha and beta) in mouse brain: mapping and neuronal localization in hippocampus. Neuroscience 43, 21-30.
3. Bandtlow C., Meyer M., Lindholm D., Spranger M., Heumann R., and Thoenen H. (1990) Regional and cellular codistribution of interleukin-1β and nerve growth factor mRNA in the adult rat brain: possible relationship to the regulation of nerve growth factor synthesis. J. Cell Biol. 111, 1701-1711.
4. 2+ accumulation. Proc. Natl. Acad. Sci. USA 92, 9328-9332.
5. Barone F., Arvin B., White B., Miller A., Webb C., Willette R., Lysko P., and Feueurstein G. (1997) Tumor necrosis factor alpha. A mediator of focal ischemic brain injury. Stroke 28, 1233-1244.
6. Bartfai T. and Schultzberg M. (1993) Cytokines in neuronal cell types. Neurochem. Int. 22, 435-444.
7. Bencsik A., Malcus C., Akaoka H., Giraudon P., Belin M., and Bernard A. (1996) Selective induction of cytokines in mouse brain infected with canine distemper virus: structural, cellular and temporal expression. J. Neuroimmunol. 65, 1-9.
8. Benveniste E. N. (1998) Cytokine actions in the central nervous system. Cytokine Growth Factor Rev. 9, 259-275.
9. Black R. A., Rauch C. T., Kozlosky C. J., Peschon J. J., Slack J. L., Wolfson M. F., Castner B. J., Stocking K. L., Reddy P., Srinivasan S., Nelson N., Boiani N., Schooley K. A., Gerhart M., Davis R., Fitzner J. N., Johnson R. S., Paxton R. J., March C. J., and Cerretti D. P. ( 1997) A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature 385, 729-733.
10. Blatteis C. M. (1990) Neuromodulative actions of cytokines. Yale J. Biol. Med. 63, 133-146.
11. Boka G., Anglade P., Wallach D., and Javoy-Agid F. (1994) Immunocytochemical analysis of TNF and its receptors in Parkinson's disease. Neurosci. Lett. 172, 151-154.
12. Breder C., Dinarello C., and Saper C. (1988) Interleukin-1 immunoreactive innervation of the human hypothalamus. Science 240, 321-324.
13. Breder C., Tsujimoto M., Terano Y., Scott D., and Saper C. (1993) Distribution and characterization of TNF-α-like immunoreactivity in the murine central nervous system. J. Camp. Neurol. 337, 543-567.
14. Bredow S., Guha-Thakurta N., Taishi P., Obal F. Jr., and Krueger J. M. (1997) Diurnal variations of tumor necrosis factor alpha mRNA and alpha-tubulin mRNA in rat brain. Neuroimmunomodulation 4, 84-90.
15. Bruce A., Boling W., Kindy M., Peschon J., Kraemer P., Carpenter M., Holtsberg F., and Mattson M. (1996) Altered neuronal and microglial responses to excitotoxic brain ischemic brain injury in mice lacking TNF receptors. Nat. Med. 2, 788-794.
16. Buttini M., Appel K., Sauter A., Gebicke-Haerter P. J., and Boddeke H. (1996) Expression of tumor necrosis factor after focal cerebral ischemia in the rat. Neuroscience 71, 1-16.
17. Caput D., Beutler B., Hartog K., Thayer R., Brown-Shimer S., and Cerami A. (1986) Identification of a common nucleotide sequence in the 3′-untranslated region of mRNA molecules specifying inflammatory mediators. Proc. Natl. Acad Sci. USA 83, 1670-1674.
18. Chambaut-Guérin A., Martinez M.-C., Hamimi C., Gauthereau X., and Nunez J. (1995) Tumor necrosis factor receptors in neuroblastoma SKNBE cells and their regulation by retinoic acid. J. Neurochem. 65, 537-544.
19. Cheng B., Christakos S., and Mattson M. (1994) Tumor necrosis factors protect neurons against metabolic-excitotoxic insults and promote maintenance of calcium homeostasis. Neuron 12, 139-153.
20. Choe W., Stoica G., Lynn W., and Wong P. (1998) Neurodegeneration induced by MoMuLV-ts1 and increased expression of Fas and TNF-α in the CNS. Brain Res. 779, 1-8.
21. Colotta F., Re F., Muzio M., Bertini R., Poletarutti N., Sironi M., Giri J., Dower S., Sims J., and Mantovani A. (1993) Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4. Science 261, 472-475.
22. Coogan A. N., O'Neill L. A., and O'Connor J. J. (1999) The p38 mitogen-activated protease kinase inhibitor SB203580 antagonizes the inhibitory effects of interleukin-1β on long-term potentiation in the rat dentate gyrus in vitro. Neuroscience 93, 57-69.
23. Cremona S., Goujon E., Kelley K. W., Dantzer R., and Parnet P. (1998a) Brain type I but not type II IL-1 receptors mediate the effects of IL-1 beta on behavior in mice. Am. J. Physiol. 274, R735-R740.
24. Cremona S., Layé S., Dantzer R., and Parnet P. (1998b) Blockade of brain type II interleukin-1 receptors potentiates IL-1 beta-induced anorexia in mice. Neurosci. Lett. 246, 101-104.
25. Cunningham E., Wada E., Carter D., Tracey D., Battey J., and De Souza E. (1991) Localization of interleukin-1 receptor messenger RNA in murine hippocampus. Endocrinology 128, 2666-2668.
26. Cunningham E., Wada E., Carter D., Tracey D., Battey J., and De Souza E. (1992) In situ histochemical localization of type I interleukin-1 receptor messenger RNA in the central nervous system, pituitary and adrenal gland on the mouse. J. Neurosci. 12, 1101-1114.
27. da Cunha A., Jefferson J. A., Jackson R. W., and Vitkovic L. (1993a) Glial cell-specific mechanisms of TGF-beta 1 induction by IL-1 in cerebral cortex. J. Neuroimmunol. 42, 71-85.
28. da Cunha A., Jefferson J. J., Tyor W. R., Glass J. D., Jannotta F. S., and Vitkovic L. (19936) Control of astrocytosis by interleukin-1 and transforming growth factor-beta 1 in human brain. Brain Res. 631, 39-45.
29. Dantzer R., Bluthe R. M., Gheusi G., Cremona S., Laye S., Parnet P., and Kelley K. W. (1998) Molecular basis of sickness behavior. Ann. NY Acad. Sci. 856, 132-138.
30. de Bock F., Dornand J., and Rondouin G. (1996) Release of TNF alpha in the rat hippocampus following epileptic seizures and excitotoxic neuronal damage. Neuroreport 7, 1125-1129.
31. de Bock F., Derijard B., Dornand J., Bockaert J., and Rondouin G. (1998) The neuronal death induced by endotoxic shock but not that induced by excitatory amino acids requires TNF-alpha. Eur. J. Neurosci. 10, 3107-3114.
32. Diana A., Van Dam A. M., Winblad B., and Schultzberg M. (1999) Co-localization of interleukin-1 receptor type I and interleukin-1 receptor antagonist with vasopressin in magnocellular neurons of the paraventricular and supraoptic nuclei of the rat hypothalamus. Neuroscience 89, 137-147.
33. Eder J. (1997) Tumour necrosis factor alpha and interleukin 1 signalling: do MAPKK kinases connect it all? Trends Pharmacol. Sci. 18, 319-322.
34. Elenkov I., Kovacs K., Duda E., Stark E., and Vizi E. (1992) Presynaptic inhibitory effect of TNF alpha on the release of noradrenaline in the median eminence. J. Neuroimmunol. 41, 117-120.
35. Ericsson A., Kovacs K. J., and Sawchenko P. E. (1994) A functional anatomical analysis of central pathways subserving the effects of interleukin-1 on stress-related neuroendocrine neurons. J. Neurosci. 14, 897-913.
36. Ericsson A., Liu C., Hart R., and Sawchenko P. (1995) Type I interleukin-1 receptor in the rat brain: distribution, regulation, and relationship to sites of IL-1-induced cellular activation. J. Comp. Neurol. 361, 681-698.
37. Fan L., Young P., Barone F., Feuerstein G., Smith D., and McIntosh T. (1995) Experimental brain injury induces expression of interleukin-1β mRNA in rat brain. Mol. Brain Res. 30, 125-130.
38. Fang J., Wang Y., and Krueger J. (1998) Effects of interleukin-1 beta on sleep are mediated by the type I receptor. Am. J. Physiol. 274, R655-R660.
39. Farrar W., Kilian P., Ruff M., Hill J., and Pert C. (1987) Visualization and characterization of interleukin-1 in the brain. J. Immunol. 139, 459-463.
40. Feueurstein G., Liu T., and Barone F. (1994) Cytokines, inflammation and brain injury: role of TNF alpha. Cerebrovasc. Brain Metab. Rev. 6, 341-360.
41. Flanders K. C., Ren R. F., and Lippa C. F. (1998) Transforming growth factor-betas in neurodegenerative disease. Prog. Neurobiol. 54, 71-85.
42. Floyd R. and Krueger J. (1997) Diurnal variation of TNF alpha in the rat brain. Neuroreport 8, 915-918.
43. Fontana A., Weber E., and Dayer J. M. (1984) Synthesis of interleukin 1/endogenous pyrogen in the brain of endotoxin-treated mice: a step in fever induction? J. Immunol. 133, 1696-1698.
44. Furukawa K. and Mattson M. P. (1998) The transcription factor NF-κB mediates increases in calcium currents and decreases in NMDA-and AMPA/kainate-induced currents induced by tumor necrosis factor-α in hippocampal neurons. J. Neurochem. 70, 1876-1886.
45. Gabellec M., Griffais R., Fillion G., and Haour F. (1996) Interleukin-1 receptors type I and type II in the mouse brain: kinetics of mRNA expressions after peripheral administration of bacterial lipopolysaccharide. J. Neuroimmunol. 66, 65-70.
46. Gabellec M. M., Crumeyrolle-Arias M., Le Saux F., Auriou N., Jacque C., and Haour F. (1999) Expression of interleukin-1 genes and interleukin-1 receptors in the mouse brain after hippocampal injury. Neurosci. Res. 33, 251-260.
47. Gatti S. and Bartfai T. (1993) Induction of tumor necrosis factor-alpha mRNA in the brain after peripheral endotoxin treatment: comparison with interleukin-1 family and interleukin-6. Brain Res. 624, 291-294.
48. Gayle D., Ilyin S. E., Flynn M. C., and Plata-Salaman C. R. (1998) Lipopolysaccharide (LPS)-and muramyl dipeptide (MDP)-induced anorexia during refeeding following acute fasting: characterization of brain cytokine and neuropeptide systems mRNAs. Brain Res. 795, 77-86.
49. Gelbard H., Dzenko K., Diloreto D., del Cerro C., del Cerro M., and Epstein L. (1993) Neurotoxic effects of TNF in primary human neuronal cultures are mediated by activation of the glutamate AMPA receptor subtype: implications for AIDS neuropathogenesis. Dev. Neurosci. 15, 417-422.
50. Goetzl E. J., Adelman D. C., and Sreedharan S. P. (1990) Neuroimmunology. Adv. Immunol. 48, 161-190.
51. Grilli M. and Memo M. (1999) Nuclear factor-kappaB/Rel proteins: a point of convergence of signalling pathways relevant in neuronal function and dysfunction. Biochem. Pharmacol. 57, 1-7.
52. Hagan P., Poole S., and Bristow A. F. (1993) Endotoxin-stimulated production of rat hypothalamic interleukin-1 beta in vivo and in vitro, measured by specific immunoradiometric assay. J. Mol. Endocrinol. 11, 31-36.
53. Higgins G. A. and Olschowka J. A. (1991) Induction of interleukin-1 beta mRNA in adult rat brain. Brain Res. Mol. Brain Res. 9, 143-148.
54. Holmin S., Schalling M., Höjeberg B., Nordqvist A. C., Skeftruna A. K., and Mathiesen T. (1997) Delayed cytokine expression in rat brain following experimental contusion. J. Neurosurg. 86, 493-504.
55. Hopkins S. J. and Rothwell N. J. (1995) Cytokines and the nervous system. I: Expression and recognition. Trends Neurosci. 18, 83-88.
56. Horai R., Asano M., Sudo K., Kanuka H., Suzuki M., Nishihara M., Takahashi M., and Iwakura Y. (1998) Production of mice deficient in genes for interleukin (IL)-1alpha, IL-1beta, IL-1alpha/beta, and IL-1 receptor antagonist shows that IL-1beta is crucial in turpentine-induced fever development and glucocorticoid secretion. J. Exp. Med. 187, 1463-1475.
57. Houzen H., Kikuchi S., Kanno M., Shinpo K., and Tashiro K. (1997) Tumor necrosis factor enhancement of transient outward potassium currents in cultured rat cortical neurons. J. Neurosci. Res. 50, 990-999.
58. Hunt J., Chen H., Hu X., Chen T., and Morrison D. (1992) Tumor necrosis factor alpha gene expression in the tissues of normal mice. Cytokine 4, 340-346.
59. Hunter C. A., Jennings F. W., Kennedy P. G., and Murray M. (1992) Astrocyte activation correlates with cytokine production in central nervous system of Trypanosoma brucei brucei-infected mice. Lab. Invest. 67, 635-642.
60. Ignatowski T. A. and Spengler R. N. (1994) Tumor necrosis factor-alpha: presynaptic sensitivity is modified after antidepressant drug administration. Brain Res. 665, 293-299.
61. Ignatowski T. A., Chou R. C., and Spengler R. N. (1996) Changes in noradrenergic sensitivity to tumor necrosis factor-alpha in brains of rats administered clonidine. J. Neuroimmunol. 70, 55-63.
62. Ignatowski T., Noble B., Wright J., Gorfien J., Heffner R., and Spengler R. (1997) Neuronal-associated TNF-alpha: its role in noradrenergic functioning and modification of its expression following antidepressant drug administration. J. Neuroimmunol. 79, 84-90.
63. Ilyin S. E. and Plata-Salaman C. R. (1997) HIV-1 gp120 modulates hypothalamic cytokine mRNAs in vivo: implications to cytokine feedback systems. Biochem. Biophvs. Res. Commun. 231, 514-518.
64. Ilyin S. E., Gayle D., Flynn M. C., and Plata-Salaman C. R. (1998) Interleukin-1beta system (ligand, receptor type I, receptor accessory protein and receptor antagonist), TNF-alpha, TCF-beta1 and neuropeptide Y mRNAs in specific brain regions during bacterial LPS-induced anorexia. Brain Res. Bull. 45, 507-515.
65. Joseph S. A., Tassorelli C., Prasad A. V., and Lynd-Balta E. (1996) NF-kappa B transcription factor subunits in rat brain: colocalization of p65 and alpha-MSH. Peptides 17, 655-664.
66. Kaltschmidt C., Kaltschmidt B., Neumann H., Wekerle H., and Baeuerle P. A. (1994) Constitutive NF-kappa B activity in neurons. Mol. Cell. Biol. 14, 3981-3992.
67. Kinouchi K., Brown G., Pasternak G., and Donner D. (1991) Identification and characterization of receptors for tumor necrosis factor alpha in the brain. Biochem. Biophys. Res. Commun. 181, 1532-1538.
68. Kluger M. J., Kozak W., Leon L. R., Soszynski D., and Conn C. A. (1998) Fever and antipyresis. Prog. Brain Res. 115, 465-475.
69. Konsman J., Kelley K., and Dantzer R. (1999) Temporal and spatial relationship between LPS-induced expression of Fos, interleukin-1 beta and inducible NO synthase in rat brain. Neuroscience 89, 535-548.
70. Krueger J. M. and Majde J. (1994) Microbial products and cytokines in sleep and fever regulation. Crit. Rev. Immunol. 14, 355-379.
71. Krueger J. M., Fang J., Taishi P., Chen Z., Kushikata T. and Gardi J. (1998) Sleep. A physiologic role for IL-1 beta and TNF-alpha. Ann. NY Acad. Sci. 856, 148-159.
72. Lalani I., Bhol K., and Ahmed A. R. (1997) Interleukin-10: biology, role in inflammation and autoimmunity. Ann. Allergy Asthma Immunol. 79, 469-483. [Published erratum appears in Ann. Allergy Asthma Immunol. 80, A6 (1998)].
73. Layé S., Goujon E., Combe C., Van Hoy R., Kelley K., Parnet P., and Dantzer R. (1996) Effects of lipopolysaccharides and glucocorticoids on expression of interleukin-1β converting enzyme in the pituitary and brain of mice. J. Neuroimmunol. 68, 61-66.
74. Lechan R., Toni R., Clark B., Cannon J., Shaw A., Dinarello C., and Reichlin S. (1990) Immunoreactive interleukin-1β localization in the rat forebrain. Brain Res. 514, 135-140.
75. Licinio J. and Wong M. L. (1997) Pathways and mechanisms for cytokine signaling of the central nervous system. J. Clin. Invest. 100, 2941-2947.
76. Licinio J., Wong M., and Gold P. (1991) Localization of interleukin-1 receptor antagonist mRNA in rat brain. Endocrinology 129, 562-564.
77. Liu T., Clark R., McDonnel P., Young P., White R., Barone F., and Feueurstein G. (1994) Tumor necrosis factor alpha expression in ischemic neurons. Stroke 25, 1481-1488.
78. Loddick S. A., Liu C., Takao T., Hashimoto K., and De Souza E. B. (1998) Interleukin-1 receptors: cloning studies and role in central nervous system disorders. Brain Res. Brain Res. Rev. 26, 306-319.
79. Luk W. P., Zhang Y., White T. D., Lue F. A., Wu C., Jiang C. G., Zhang L., and Moldofsky H. (1999) Adenosine: a mediator of interleukin-1beta-induced hippocampal synaptic inhibition. J. Neurosci. 19, 4238-4244.
80. Mackiewicz M., Sollars P. J., Ogilvie M. D., and Pack A. I. (1996) Modulation of IL-1 beta gene expression in the rat CNS during sleep deprivation. Neuroreport 7, 529-533.
81. Marino M., Dunn A., Grail D., Inglese M., Noguchi Y., Richards E., Jungbluth A., Wada H., Moore M., Williamson B., Basu S., and Old L. (1997) Characterization of tumor necrosis factor-deficient mice. Proc. Natl. Acad. Sci. USA 94, 8093-8098.
82. Mattson M. P., Barger S. W., Furukawa K., Bruce A. J., Wyss-Coray T., Mark R. J., and Mucke L. (1997) Cellular signaling roles of TGF beta, TNF alpha and beta APP in brain injury responses and Alzheimer's disease. Brain Res. Brain Res. Rev. 23, 47-61.
83. McCann S. M., Kimura M., Karanth S., Yu W. H., and Rettori V. (1997) Nitric oxide controls the hypothalamic-pituitary response to cytokines. Neuroimmunomodulation 4, 98-106.
84. Medana I., Hunt N., and Chaudhri G. (1997) Tumor necrosis factor alpha expression in the brain during fatal murine cerebral malaria. Am. J. Pathol. 150, 1473-1486.
85. Meltzer J. C., Sanders V., Grimm P. C., Stern E., Rivier C., Lee S., Rennie S. L., Gietz R. D., Hole A. K., Watson P. H., Greenberg A. H., and Nance D. M. (1998) Production of digoxigenin-labelled RNA probes and the detection of cytokine mRNA in rat spleen and brain by in situ hybridization. Brain Res. Brain Res. Protoc. 2, 339-351.
86. Merrill J. E. and Benveniste E. N. (1996) Cytokines in inflammatory brain lesions: helpful and harmful. Trends Neurosci. 19, 331-338.
87. Minami M., Kuraishi Y., Yabuuchi K., Yamazaki A., and Satoh M. (1992) Induction of interleukin-1β mRNA in rat brain after transient forebrain ischemia. J. Neurochem. 58, 390-392.
88. Molenaar G. J., Berkenbosch F., van Dam A. M., and Lugard C. M. (1993) Distribution of interleukin 1 beta immunoreactivity within the porcine hypothalamus. Brain Res. 608, 169-174.
89. Moss M. L., Jin S. L., Milla M. E., Bickett D. M., Burkhart W., Carter H. L., Chen W. J., Clay W. C., Didsbury J. R., Hassler D., Hoffman C. R., Kost T. A., Lambert M. H., Leesnitzer M. A., McCauley P., McGeehan G., Mitchell J., Moyer M., Pahel G., Rocque W., Overton L. K., Schoenen F., Seaton T., Su J. L., Becherer J. D., et al. (1997) Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha. Nature 385, 733-736. [Published erratum appears in Nature 386, 738 (1997)].
90. Murray C. and Lynch M. (1998) Evidence that increased hippocampal expression of the cytokine interleukin-1 beta is a common trigger for age-and stress-induced impairments in long-term potentiation. J. Neurosci. 18, 2974-2981.
91. Nguyen K. T., Deak T., Owens S. M., Kohno T., Fleshner M., Watkins L. R., and Maier S. F. (1998) Exposure to acute stress induces brain interleukin-1beta protein in the rat. J. Neurosci. 18, 2239-2246.
92. Nishiyori A., Minami M., Takami S., and Satoh M. (1997) Type II interleukin-1 receptor mRNA is induced by kainic acid in the rat brain. Mol Brain Res. 50, 237-245.
93. O'Neill L. A. and Kaltschmidt C. (1997) NF-kappa B: a crucial transcription factor for glial and neuronal cell function. Trends Neurosci. 20, 252-258.
94. Pan W., Zadina J., Harlan R., Weber J., Banks W., and Kastin A. (1997) Tumor necrosis-alpha: a neuromodulator in the CNS. Neurosci. Biobehav. Rev. 21, 603-613.
95. Parnet P., Amindari S., Wu C., Brunke-Reese D., Goujon E., Weyhenmeyer J., Dantzer R., and Kelley K. (1994) Expression of type I and type II interleukin-1 receptors in mouse brain. Mol. Brain Res. 27, 63-70.
96. Pestarino M., De Anna E., Masini M. A., and Sturla M. (1997) Localization of interleukin-1 beta mRNA in the cerebral ganglion of the protochordate, Styela plicata. Neurosci. Lett. 222, 151-154.
97. Pitossi F., del Rey A., Kabiersch A., and Besedovsky H. (1997) Induction of cytokine transcripts in the CNS and pituitary following peripheral administration of endotoxin to mice. J. Neurosci. Res. 48, 287-298.
98. Plata-Salaman C. R. (1991) Immunoregulators in the nervous system. Neurosci. Biobehav. Rev. 15, 185-215.
99. Plata-Salaman C. R. (1998) Cytokine-induced anorexia. Behavioral, cellular, and molecular mechanisms. Ann. NY Acad. Sci. 856, 160-170.
100. 2+ channel currents in hippocampal neurons through protein kinase C. Eur. J. Pharmacol. 266, 1-10.
101. Plata-Salaman C. R., Oomura Y., and Kai Y. (1988) Tumor necrosis factor and interleukin-1 beta: suppression of food intake by direct action in the central nervous system. Brain Res. 448, 106-114.
102. Plata-Salaman C. R., Ilyin S. E., and Gayle D. (1998a) Brain cytokine mRNAs in anorectic rats bearing prostate adenocarcinoma tumor cells. Am. J. Physiol. 275, R566-R573.
103. Plata-Salaman C. R., Ilyin S. E., Gayle D., and Flynn M. C. (1998b) Gram-negative and gram-positive bacterial products induce differential cytokine profiles in the brain: analysis using an integrative molecular-behavioral in vivo model. Int. J. Mol. Med. 1, 387-397.
104. Plata-Salaman C. R., Wilson C. D., and Ffrench-Mullen J. M. (1998c) In vivo IL-1beta-induced modulation of G-protein alphaO subunit subclass in the hypothalamic ventromedial nucleus: implications to IL-1beta-associated anorexia. Brain Res. Mol. Brain Res. 58, 188-194.
105. Pousset F. (1994) Developmental expression of cytokine genes in the cortex and hippocampus of the rat central nervous system. Dev. Brain Res. 81, 143-146.
106. Pratt B. M. and McPherson J. M. (1997) TGF-beta in the central nervous system: potential roles in ischemic injury and neurodegenerative diseases. Cytokine Growth Factor Rev. 8, 267-292.
107. Pringle A. K., Gardner C. R., and Walker R. J. (1996) Reduction of cerebellar GABAA responses by interleukin-1 (IL-1) through an indomethacin insensitive mechanism. Neuropharmacology 35, 147-152.
108. Quan N., Zhang Z., Emery M., Bonsall R., and Weiss J. M. (1996) Detection of interleukin-1 bioactivity in various brain regions of normal healthy rats. Neuroimmunomodulation 3, 47-55.
109. Quan N., Whiteside M., and Herkenham M. (1998) Time course and localization patterns of interleukin-1 beta mRNA expression in brain and pituitary after peripheral administration of lipopolysaccharide. Neuroscience 83, 281-293.
110. Rettori V., Dees W. L., Hiney J. K., Lyson K., and McCann S. M. (1994) An interleukin-1-alpha-like neuronal system in the preoptic-hypothalamic region and its induction by bacterial lipopolysaccharide in concentrations which alter pituitary hormone release. Neuroimmunomodulation 1, 251-258.
111. Rothwell N. J. and Hopkins S. J. (1995) Cytokines and the nervous system. II: Actions and mechanisms of action. Trends Neurosci. 18, 130-136.
112. Sacoccio C., Dornand J., and Barbanel G. (1998) Differential regulation of brain and plasma TNF-alpha produced after endotoxin shock. Neuroreport 9, 309-313.
113. Saito K., Suyama K., Nishida K., Sei Y., and Basile A. (1996) Early increases in TNF-α, IL-6 and IL-1β levels following transient cerebral ischemia in gerbil brain. Neurosci. Lett. 206, 149-152.
114. Schneider H., Pitossi F., Balschun D., Wagner A., del Rey A., and Besedovsky H. O. (1998) A neuromodulatory role of interleukin-1beta in the hippocampus. Proc. Natl. Acad. Sci. USA 95, 7778-7783.
115. Schöbitz B., Holsboer F., and de Kloet E. (1994) Gene expression and function of interleukin-1, interleukin-6 and tumor necrosis factor in the brain. Prog. Neurobiol. 44, 397-432.
116. Sei Y., Vitkovic L., and Yokoyama M. M. (1995) Cytokines in the central nervous system: regulatory roles in neuronal function, cell death and repair. Neuroimmunomodulation 2, 121-133.
117. Sheng J., Mrak R., and Griffin W. (1998) Enlarged and phagocytic, but not primed, interleukin-1 alpha-immunoreactive microglia increase with age in normal human brain. Acta Neuropathol. (Berl.) 95, 229-234.
118. Shintani F., Nakaki T., Kanba S., Sato K., Yagi G., Shiozawa M., Aiso S., Kato R., and Asai M. (1995) Involvement of interleukin-1 in immobilization stress-induced increase in plasma adrenocorticotropic hormone and in release of hypothalamic monoamines in the rat. J. Neurosci. 15, 1961-1970.
119. 2+ currents in cultured sympathetic neurons. J. Neurosci. 12, 2665-2671.
120. Streit W. J., Semple-Rowland S. L., Hurley S. D., Miller R. C., Popovich P. G., and Stokes B. T. (1998) Cytokine mRNA profiles in contused spinal cord and axotomized facial nucleus suggest a beneficial role for inflammation and gliosis. Exp. Neurol. 152, 74-87.
121. Swiergiel A. H., Smagin G. N., Johnson L. J., and Dunn A. J. (1997) The role of cytokines in the behavioral responses to endotoxin and influenza virus infection in mice: effects of acute and chronic administration of the interleukin-1-receptor antagonist (IL-1ra). Brain Res. 776, 96-104.
122. Taishi P., Bredow S., Guha-Thakurta N., Obal F. Jr., and Krueger J. M. (1997) Diurnal variations of interleukin-1 beta mRNA and beta-actin mRNA in rat brain. J. Neuroimmunol. 75, 69-74.
123. Taishi P., Chen Z., Obal F., Hansen M., Zhang J., Fang J., and Krueger J. (1998) Sleep-associated changes in interleukin-1 beta mRNA in the brain. J. Interferon Cytokine Res. 18, 793-798.
124. Takahashi S., Fang J., Kapas L., Wang Y., and Krueger J. (1997) Inhibition of brain IL-1 attenuates sleep rebound after sleep deprivation in rabbits. Am. J. Physiol. 273, R677-R682.
125. Takao T., Tracey D., Mitchell M., and De Souza E. (1990) Interleukin-1 receptors in mouse brain: characterization and neuronal localization. Endocrinology 127, 3070-3078.
126. Talley A., Dewhurst S., Perry S., Dollard S., Gummuluru S., Fine S., New D., Epstein L., Gendelman H., and Gelbard H. (1995) Tumor necrosis alpha-induced apoptosis in human neuronal cells: protection by the antioxidant N-acetylcysteine and the genes bcl-2 and crmA. Mol. Cell. Biol. 15, 2359-2366.
127. Tartaglia L., Weber R., Figari I., Reynolds C., Palladino M., and Goeddel D. (1991) The two different receptors for tumor necrosis factor mediate distinct cellular responses. Proc. Natl. Acad. Sci. USA 88, 9292-9295.
128. Tartaglia L., Rothe M., Hu R., and Goeddel D. (1993) Tumor necrosis factor's cytotoxic activity is signaled by p55 TNF receptor. Cell 73, 213-216.
129. Tchélingérian J., Quinonero J., Booss J., and Jacque C. (1993) Localization of TNF alpha and IL-1 alpha immunoreactivities in striatal neurons after surgical injury to the hippocampus. Neuron 10, 213-224.
130. Tchélingérian J., Vignais L., and Jacque C. (1994) TNF alpha gene expression is induced in neurons after hippocampal lesion. Neuroreport 5, 585-588.
131. Tchélingérian J., Monge M., Le Saux F., Zalc B., and Jacque C. (1995) Differential oligodendroglial expression of the tumor necrosis factor receptors in vivo and in vitro. J. Neurochem. 65, 2377-2380.
132. Terao A., Oikawa M., and Saito M. (1993) Cytokine-induced change in hypothalamic norepinephrine turnover: involvement of corticotropin-releasing hormone and prostaglandins. Brain Res. 622, 257-261.
133. Tingsborg S., Zetterström M., Alheim K., Hasanvan H., Schultzberg M., and Bartfai T. (1996) Regionally specific induction of ICE mRNA and enzyme activity in the rat brain and adrenal gland by LPS. Brain Res. 712, 153-158.
134. Tringali G., Mirtella A., Mancuso C., Guerriero G., Preziosi P., and Navarra P. (1997) The release of immunoreactive interleukin-1 beta from rat hypothalamic explants is modulated by neurotransmitters and corticotropin-releasing hormone. Pharmacol. Res. 36, 269-273.
135. Turnbull A. V. and Rivier C. L. (1999) Regulation of the hypothalamic-pituitary-adrenal axis by cytokines: actions and mechanisms of action. Physiol. Rev. 79, 1-71.
136. Turnbull A., Pitossi F., Lebrun J., Lee S., Meltzer J., Nunce D., del Rey A., Besedovsky H., and Rivier C. (1997) Inhibition of tumor necrosis factor alpha action within the CNS markedly reduces the plasma adrenocorticotrophin response to peripheral local inflammation in rats. J. Neurosci. 17, 3262-3273.
137. Van Antwerp D. J., Martin S. J., Verma I. M., and Green D. R. (1998) Inhibition of TNF-induced apoptosis by NF-kappa B. Trends Cell Biol. 8, 107-111.
138. Van Dam A. M., Bauer J., Tilders F. J., and Berkenbosch F. (1995) Endotoxin-induced appearance of immunoreactive interleukin-1 beta in ramified microglia in rat brain: a light and electron microscopic study. Neuroscience 65, 815-826.
139. Wang Y., Lin S. Z., Chiou A. L., Williams L. R., and Hoffer B. J. (1997) Glial cell line-derived neurotrophic factor protects against ischemia-induced injury in the cerebral cortex. J. Neurosci. 17, 4341-4348.
140. Watkins L. R., Nguyen K. T., Lee J. E., and Maier S. F. (1999) Dynamic regulation of proinflammatory cytokines. Adv. Exp. Med. Biol. 461, 153-178.
141. Wesselingh S. L., Power C., Glass J. D., Tyor W. R., McArthur J. C., Farber J. M., Griffin J. W., and Griffin D. E. (1993) Intracerebral cytokine messenger RNA expression in acquired immunodefi-ciency syndrome dementia. Ann. Neurol. 33, 576-582.
142. Wilkinson M. F., Mathieson W. B., and Pittman Q. J. (1993) Interleukin-1 beta has excitatory effects on neurons of the bed nucleus of the stria terminalis. Brain Res. 625, 342-346.
143. Wilt S., Milward E., Zhou J., Nagasato K., Patton H., Rusten R., Griffin D., O'Connor M., and Dubois-Dalcq M. (1995) In vitro evidence for a dual role of tumor necrosis factor alpha in human immunodeficiency virus type 1 encephalopathy. Ann. Neurol. 37, 381-394.
144. Wolvers D., Marquette C., Berkenbosch F., and Haour F. (1993) Tumor necrosis factor alpha: specific binding sites in rodent brain and pituitary gland. Eur. Cytokine Netw. 4, 377-381.
145. Wong M. and Licinio J. (1994) Localization of interleukin-1 type 1 receptor mRNA in rat brain. Neuroimmunomodulation 1, 110-115.
146. Yabuuchi K., Minami M., Katsumata S., and Satoh M. (1994) Localization of type I interleukin-1 receptor mRNA in the rat brain. Mol. Brain Res. 27, 27-36.
147. Yasuhara O., Matsuo A., Terai K., Walker D. G., Berger A. E., Akiguchi I., Kimura J., and McGeer P. L. (1997) Expression of interleukin-1 receptor antagonist protein in post-mortem human brain tissues of Alzheimer's disease and control cases. Acta Neuropathol. (Berl.) 93, 414-420.
148. Zhao B. and Schwartz J. (1998) Involvement of cytokines in normal CNS development and neurological diseases: recent progress and perspectives. J. Neurosci. Res. 52, 7-16.